Pfizer Trump Drug Prices: A Landmark Deal for A...

By Rene Pretorius

October 1, 2025

Summary President Trump announced that Pfizer has agreed to lower drug prices. This is part of a broader initiative to reduce prescription d...
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic ...
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
The Market Dynamics of Track One Patent Strategy in Pharmaceuticals
Biosimilars Market Trends 2025: Understanding Erosion and Growth
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control
NICE Kidney Cancer Guideline: Enhancing Biopsy Use to Minimize Unnecessary Su...
Mounjaro Price Increase UK: Impacts on Access and Health Economics
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
TAVI Cost-Effectiveness in Brazil: Balancing Coverage Expansion and Economic ...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit